The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Media releases

Media release: 
28/06/2017

Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial

Media release: 
25/06/2017

As one of the largest basal insulin research projects in China, the Observational Registry for Basal Insulin Treatment (ORBIT) project was initiated by the Chinese Diabetes Society (CDS), conducted and managed by The George Institute, China and supported by Sanofi China. ORBIT was launched in 2011 and has successfully published research findings this year after the positive participation of 209 secondary and tertiary hospitals nationwide, hundreds of doctors and follow-up of nearly 20,000 patients with type 2 diabetes for 6 months.

Media release: 
22/06/2017

A trial involving more than 11,000 patients has revealed sitting up or lying flat after a stroke makes no difference to their recovery.

Media release: 
13/06/2017

A drug that lowers blood sugar levels for people with type 2 diabetes has also been revealed to significantly reduce the risk of both cardiovascular and kidney disease.

Media release: 
12/06/2017

In the 2017 Queen's Birthday Honours List, Professors Robyn Norton and Stephen MacMahon, the founders and principal directors of The George Institute for Global Health, were appointed Officers in the General Division of the Order of Australia (AO).

Media release: 
18/05/2017

Journalists from low and middle income countries took part in a three day road safety fellowship program last week co-hosted by The George Institute and the World Health Organisation (WHO).

Media release: 
18/05/2017

The George Institute, China, has won an AustCham Westpac Australia-China Business Award (ACBA) in the category of Business Excellence for Sustainability, Diversity and Social Responsibility.

Media release: 
25/04/2017

On 19 April 2017, Professor Craig Anderson, Executive Director of the George Institute China received a new appointment as a guest professor at Chengdu Medical College (CMC).

Media release: 
20/04/2017

Clinical Pathways for Acute Coronary Syndromes in China (CPACS-3) research from The George Institute China has revealed factors attributed to the higher in-hospital mortality of ST elevation myocardial infarction (STEMI) patients admitted during off-hour in comparison with those during regular hours.

Media release: 
12/04/2017

The George Institute, China has been selected as a finalist in the AustCham Westpac Australia-China Business Awards (ACBA) of 2017, in the Business Excellence for Sustainability, Diversity and Social Responsibility category.

Pages